Hydrochloric Acid → (1R,2R)-2-methyl-cyclopropanecarboxylic acid [3-(2-methyl-2H-indazol-5-yl)-4-pyridin-2-yl-isothiazol-5-yl]-amide hydrochloride
反応式
Br[C:2]1[N:7]=[C:6](N(C)C)[CH:5]=[CH:4][CH:3]=1.Br[C:12]1[C:13]([C:24]2[CH:32]=[CH:31][C:30]3[C:26](=[CH:27][N:28]([CH2:33]C)[N:29]=3)[CH:25]=2)=[N:14][S:15][C:16]=1[NH:17][C:18]([C@@H:20]1[CH2:22][C@H:21]1[CH3:23])=[O:19].BrC1C(C2C=CC3C(=CN(C)N=3)C=2)=NSC=1NC([C@@H]1C[C@H]1C)=O.[ClH:58]>>[ClH:58].[CH3:33][N:28]1[CH:27]=[C:26]2[C:30]([CH:31]=[CH:32][C:24]([C:13]3[C:12]([C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][N:7]=4)=[C:16]([NH:17][C:18]([C@@H:20]4[CH2:22][C@H:21]4[CH3:23])=[O:19])[S:15][N:14]=3)=[CH:25]2)=[N:29]1参加物
5
反応物 4
生成物 1
実験手順
The following compounds are prepared essentially as described in Example 5 using (6-bromo-pyridin-2-yl)-dimethyl-amine and either (1R,2R)-2-methyl-cyclopropanecarboxylic acid [4-bromo-3-(2-ethyl-2H-indazol-5-yl)-isothiazol-5-yl]-amide or (1R,2R)-2-methyl-cyclopropanecarboxylic acid [4-bromo-3-(2-methyl-2H-indazol-5-yl)-isothiazol-5-yl]-amide. Example 7; is prepared as the free base by omitting treatment with hydrogen chloride.
後処理
- customThe following compounds are prepared essentially
- customis prepared as the free base
出典と根拠
- ORDレコード
- ord-17b82e23b7e7447a9ed64ca2b565f35e
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07932274B2
反応ノート
読み込み中…